🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This randomized, double-blind, parallel group study compares the efficacy a...
Status
Completed
Location
Multiple Locations
Start Date
2010-09
Trial ID
NCT01194414
This observational trial will evaluate the effectiveness, the consistency o...
Status
Completed
Location
ASZ Aalst
Start Date
2015-10-31
Trial ID
NCT02552940
Treatments Being Tested
This 2 arm study will assess the safety and efficacy of tocilizumab monothe...
Status
Completed
Location
Multiple Locations
Start Date
2005-07
Trial ID
NCT00109408
Treatments Being Tested
This open-label extension study will evaluate the long-term safety and effi...
Status
Completed
Location
Multiple Locations
Start Date
2012-08
Trial ID
NCT01662063
Treatments Being Tested
The goal of this clinical trial is to investigate the immunomodulatory effe...
Status
Recruiting
Location
Intensive Care Medicine, Radboud University Nijmegen Medical Centre
Start Date
2024-10-24
Trial ID
NCT06624436
Treatments Being Tested
This prospective, multi-center, observational study will evaluate factors i...
Status
Completed
Location
Multiple Locations
Start Date
2012-01
Trial ID
NCT01474291
Treatments Being Tested
This nationwide, multicenter, single arm, prospective, non-interventional s...
Status
Completed
Location
Rheumazentrum Kupka
Start Date
2017-01-12
Trial ID
NCT03112213
Treatments Being Tested
Primary objectives of the study are to investigate whether adjuvant treatme...
Status
Terminated
Location
Milo Stanisic
Start Date
2017-11-28
Trial ID
NCT03353259
Treatments Being Tested
In a Phase 2 Simon's Optimal Two-Stages Design intravenous tocilizumab will...
Status
Unknown
Location
Università Politecnica delle Marche
Start Date
2020-03-12
Trial ID
NCT04315480
Treatments Being Tested
This open-label study will evaluate the efficacy and safety of tocilizumab ...
Status
Completed
Location
Aberdeen Royal Infirmary
Start Date
2014-03-04
Trial ID
NCT02046603
Treatments Being Tested